immunochemotherapy Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 2 (2)
Unknown (1)

INTERVENTIONAL (1)
Interventional (1)
Observational (1)

Lorenza Scotti (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Sun Yat-sen University (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadpneumonia

I am/have/hadtransient ischemic attack

I am/have/hadinterstitial lung disease

I am/have/hadadjuvant therapy

I am/have/hadlung cancer

I am/have/hadhematologic malignancy

I am/have/hadstroke

I am/have/hadblood pregnancy test

I am/have/hadplatelet count

I am/have/hadsmall cell lung cancer

I am/have/hadliver disease

I am/have/hadmyocardial infarction

I am/have/hadpulmonary disease

I am/have/hadcancer

I am/have/hadnon-small cell lung cancer

I am/have/hadproteinuria

I am/have/hadblood test

I am/have/hadneutrophil count

I am/have/hadhepatitis

I am/have/hadtuberculosis

added new label for I am/have/had

I am looking for

I am looking forcarboplatin

I am looking forgranulocyte colony stimulating factor

I am looking forg-csf

I am looking forpaclitaxel

I am looking forcolony stimulating factor

I am looking forpemetrexed

I am looking forsintilimab

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Includes pre-screening
Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC (PROPHET)

Are additional cycles of immunochemotherapy necessary for patients who have ctDNA clearance after initial cycles of treatment? Researchers will use ctDNA dynamics to guide the cycles of induction treatment to see if some patients can avoid excessive cycles of treatment.

0 views
23 Jun, 2025

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC neoSCORE

This trial will also explore the biomarkers of neoadjuvant immunochemotherapy.

pneumonia

paclitaxel

transient ischemic attack

interstitial lung disease

adjuvant therapy

0 views
05 Aug, 2020

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Family Medicine
Recruiting

Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients

Impact of the Comprehensive Geriatric Assessment on the Quality of Life of elderly onco-hematologic patients' candidates for complex antitumoral therapies: clinical and biological correlatives

cancer

hematologic malignancy

0 views
05 Aug, 2020